{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:36Z","timestamp":1791919056865,"version":"4.3.4"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:00:00Z","timestamp":1348185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s12035-012-8348-8","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T13:28:56Z","timestamp":1348147736000},"page":"90-104","source":"Crossref","is-referenced-by-count":92,"title":["Spinocerebellar Ataxia Type 2: Clinical Presentation, Molecular Mechanisms, and Therapeutic Perspectives"],"prefix":"10.1007","volume":"47","author":[{"given":"J. J.","family":"Maga\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vel\u00e1zquez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,21]]},"reference":[{"key":"8348_CR1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621. doi: 10.1146\/annurev.neuro.29.051605.113042","journal-title":"Annu Rev Neurosci"},{"key":"8348_CR2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/74249","volume":"24","author":"H Ellegren","year":"2000","unstructured":"Ellegren H (2000) Heterogeneous mutation processes in human microsatellite DNA sequences. Nat Genet 24:400\u20132. doi: 10.1038\/74249","journal-title":"Nat Genet"},{"key":"8348_CR3","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1471-4159.2009.06302.x","volume":"110","author":"PO Bauer","year":"2009","unstructured":"Bauer PO, Nukina N (2009) The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J Neurochem 110:1737\u20131765. doi: 10.1111\/j.1471-4159.2009.06302.x","journal-title":"J Neurochem"},{"key":"8348_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/105.1.1","volume":"105","author":"AE Harding","year":"1982","unstructured":"Harding AE (1982) The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the Drew family of Walworth. Brain 105:1\u201328. doi: 10.1093\/brain\/105.1.1","journal-title":"Brain"},{"key":"8348_CR5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"A Durr","year":"2010","unstructured":"Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9:885\u201394. doi: 10.1016\/S1474-4422(10)70183-6","journal-title":"Lancet Neurol"},{"key":"8348_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WNO0b013e3181b416de","volume":"29","author":"HL Paulson","year":"2009","unstructured":"Paulson HL (2009) The spinocerebellar ataxias. J Neuroophthalmol 29:227\u201337. doi: 10.1097\/WNO0b013e3181b416de","journal-title":"J Neuroophthalmol"},{"key":"8348_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14734220510007914","volume":"4","author":"MU Manto","year":"2005","unstructured":"Manto MU (2005) The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 4:2\u20136. doi: 10.1080\/14734220510007914","journal-title":"Cerebellum"},{"issue":"4","key":"8348_CR8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1590\/S0004-282X2009000600035","volume":"67","author":"HA Teive","year":"2009","unstructured":"Teive HA (2009) Spinocerebellar ataxias. Arq Neuropsiquiatr 67(4):1133\u201342. doi: 10.1590\/S0004-282X2009000600035","journal-title":"Arq Neuropsiquiatr"},{"key":"8348_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/187221512801327442","volume":"6","author":"A Trott","year":"2012","unstructured":"Trott A, Houenou LJ (2012) Mini-review: spinocerebellar ataxias: an update of SCA genes. Recent Pat DNA Gene Seq 6:115\u2013121","journal-title":"Recent Pat DNA Gene Seq"},{"key":"8348_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson CE, Nichol-Edamura K, Cleary JD (2005) Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6:729\u201342. doi: 10.1083\/nrg1689","journal-title":"Nat Rev Genet"},{"key":"8348_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2009.03.015","volume":"454","author":"L Vel\u00e1zquez P\u00e9rez","year":"2009","unstructured":"Vel\u00e1zquez P\u00e9rez L, Cruz GS, Santos Falc\u00f3n N, Enrique Almaguer Mederos L, Escalona Batallan K, Rodr\u00edguez Labrada R et al (2009) Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holgu\u00edn. Neurosci Lett 454:157\u201360. doi: 10.1016\/j.neulet.2009.03.015","journal-title":"Neurosci Lett"},{"key":"8348_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s004390051026","volume":"106","author":"Q Saleem","year":"2000","unstructured":"Saleem Q, Choudhry S, Mukerji M, Bashyam L, Padma MV, Chakravarthy A et al (2000) Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet 106:179\u201387. doi: 10.1007\/s004390051026","journal-title":"Hum Genet"},{"issue":"2","key":"8348_CR13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12311-011-0265-2","volume":"10","author":"L Vel\u00e1zquez P\u00e9rez","year":"2011","unstructured":"Vel\u00e1zquez P\u00e9rez L, Rodr\u00edguez Labrada R, Garc\u00eda Rodr\u00edguez JC, Almaguer Mederos LE, Cruz-Mari\u00f1o T, Laffita-Mesa JM (2011) A comprehensive review of spinocerebellar ataxia type 2 in Cuba. Cerebellum 10(2):184\u2013198. doi: 10.1007\/s12311-011-0265-2","journal-title":"Cerebellum"},{"key":"8348_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1399-0004.2006.00656.x","volume":"70","author":"A Trott","year":"2006","unstructured":"Trott A, Jardim LB, Ludwig HT, Saute JA, Artigal\u00e1s O, Kieling C, Wanderley HY et al (2006) Spinocerebellar ataxias in 114 Brazilian families: clinical and molecular findings. Clin Genet 70:173\u2013176. doi: 10.1111\/j.1399-0004.2006.00656.x","journal-title":"Clin Genet"},{"key":"8348_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.33588\/rn.3207.2000566","volume":"32","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2001","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Garc\u00eda R, Santos FN, Paneque HM, Medina HE, Hechavarr\u00eda PR (2001) Epidemiology of Cuban hereditary ataxias. Rev Neurol 32:606\u201311","journal-title":"Rev Neurol"},{"key":"8348_CR16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/mds.21470","volume":"22","author":"E Alonso","year":"2007","unstructured":"Alonso E, Mart\u00ednez-Ruano L, De Biase I, Mader C, Ochoa A, Yescas P et al (2007) Distinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Mov Disord 22:1050\u20133. doi: 10.1002\/mds.21470","journal-title":"Mov Disord"},{"key":"8348_CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/94.2.359","volume":"94","author":"NH Wadia","year":"1971","unstructured":"Wadia NH, Swami RK (1971) A new form of heredo-familiar spinocerebellar degeneration with slow eye movements (nine families). Brain 94:359\u201374. doi: 10.1093\/brain\/94.2.359","journal-title":"Brain"},{"key":"8348_CR18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20220","volume":"56","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2004","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Seifried C, Santos-Falc\u00f3n N, Abele M, Ziemann U, Almaguer LE et al (2004) Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann Neurol 56:444\u20137. doi: 10.1002\/ana.20220","journal-title":"Ann Neurol"},{"key":"8348_CR19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clinph.2008.12.040","volume":"120","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2009","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Seifried C, Abele M, Wirjatijasa F, Rodr\u00edguez-Labrada R, Santos-Falc\u00f3n N et al (2009) Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clin Neurophysiol 120:632\u20135. doi: 10.1016\/j.clinph.2008.12.040","journal-title":"Clin Neurophysiol"},{"key":"8348_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2007.07.013","volume":"263","author":"L Vel\u00e1zquez P\u00e9rez","year":"2007","unstructured":"Vel\u00e1zquez P\u00e9rez L, S\u00e1nchez Cruz G, Canales Ochoa N, Rodr\u00edguez Labrada R, Rodr\u00edguez D\u00edaz J, Almaguer Mederos L et al (2007) Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci 263:158\u201364. doi: 10.1016\/j.jns.2007.07.013","journal-title":"J Neurol Sci"},{"key":"8348_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2009.12.013","volume":"290","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2010","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez-Labrada R, Canales-Ochoa N, S\u00e1nchez-Cruz G, Fern\u00e1ndez-Ruiz J, Montero JM et al (2010) Progression markers of spinocerebellar ataxia 2. A twenty years neurophysiological follow up study. J Neurol Sci 290:22\u20136. doi: 10.1016\/j.jns.2009.12.013","journal-title":"J Neurol Sci"},{"key":"8348_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.23409","volume":"26","author":"R Rodr\u00edguez-Labrada","year":"2011","unstructured":"Rodr\u00edguez-Labrada R, Vel\u00e1zquez-P\u00e9rez L, Canales-Ochoa N, Galicia-Polo L, Haro-Valencia R, S\u00e1nchez-Cruz G et al (2011) Subtle REM sleep abnormalities in presymptomatic spinocerebellar ataxia type 2 gene carriers. Mov Disord 26:347\u201350. doi: 10.1002\/mds.23409","journal-title":"Mov Disord"},{"key":"8348_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0079-6123(08)00683-3","volume":"171","author":"S Geiner","year":"2008","unstructured":"Geiner S, Horn AK, Wadia NH, Sakai H, B\u00fcttner-Ennever JA (2008) The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog Brain Res 171:575\u201381. doi: 10.1016\/S0079-6123(08)00683-3","journal-title":"Prog Brain Res"},{"key":"8348_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mds.20636","volume":"21","author":"AL Rosa","year":"2006","unstructured":"Rosa AL, Molina I, Kowaljow V, Conde CB (2006) Brisk deep-tendon reflexes as a distinctive phenotype in an Argentinean spinocerebellar ataxia type 2 pedigree. Mov Disord 21:66\u201368. doi: 10.1002\/mds.20636","journal-title":"Mov Disord"},{"key":"8348_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.20074","volume":"19","author":"S Furtado","year":"2004","unstructured":"Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA et al (2004) Profile of families with parkinsonism predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19:622\u20139. doi: 10.1002\/mds.20074","journal-title":"Mov Disord"},{"key":"8348_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2005.03.015","volume":"382","author":"J Simon-S\u00e1nchez","year":"2005","unstructured":"Simon-S\u00e1nchez J, Hanson M, Singleton A, Hern\u00e1ndez D, McInerney A, Nussbaum R et al (2005) Analysis of SCA-2 and SCA-3 repeats in parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson\u2019s disease. Neurosci Lett 382:191\u20134. doi: 10.1016\/j.neulet.2005.03.015","journal-title":"Neurosci Lett"},{"key":"8348_CR27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00415-006-0183-2","volume":"253","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2006","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Fern\u00e1ndez-Ruiz J, D\u00edaz R, Gonz\u00e1lez RP, Ochoa NC, Cruz GS et al (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 253:1165\u20139. doi: 10.1007\/s00415-006-0183-2","journal-title":"J Neurol"},{"key":"8348_CR28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.33588\/rn.3509.2002300","volume":"35","author":"RD Reynaldo-Armi\u00f1\u00e1n","year":"2002","unstructured":"Reynaldo-Armi\u00f1\u00e1n RD, Reynaldo-Hern\u00e1ndez R, Paneque-Herrera M, Prieto-\u00c1vila L, P\u00e9rez-Ruiz E (2002) Mental disorders in patients with spinocerebellar ataxia type 2 in Cuba. Rev Neurol 35:818\u201321","journal-title":"Rev Neurol"},{"key":"8348_CR29","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.neuropsychologia.2007.04.006","volume":"45","author":"J Fern\u00e1ndez-Ruiz","year":"2007","unstructured":"Fern\u00e1ndez-Ruiz J, Vel\u00e1squez-P\u00e9rez L, D\u00edaz R, Drucker-Col\u00edn R, P\u00e9rez-Gonz\u00e1lez R, Canales N (2007) Prism adaptation in spinocerebellar ataxia type 2. Neuropsychologia 45:2692\u20138","journal-title":"Neuropsychologia"},{"key":"8348_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1096-8628(19981012)79:5<383::AID-AJMG10>3.0.CO;2-N","volume":"79","author":"D Babovic-Vuksanovic","year":"1998","unstructured":"Babovic-Vuksanovic D, Snow K, Patterson MC, Michels W (1998) Spinocerebellar ataxia type 2 (SCA2) in an infant with extreme CAG repeat expansion. Am J Med Genet 79:383\u20137. doi: 10.1002\/(SICI)1096-8628(19981012)7","journal-title":"Am J Med Genet"},{"key":"8348_CR31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000047968","volume":"47","author":"A Rufa","year":"2002","unstructured":"Rufa A, Dotti MT, Gali L, Orrico A, Sicurelli F, Federico A (2002) Spinocerebellar ataxia type 2 (SCA2) associated with retinal pigmentary degeneration. Eur Neurol 47:128\u20139. doi: 10.1159\/000047968","journal-title":"Eur Neurol"},{"key":"8348_CR32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.10467","volume":"110","author":"R Mao","year":"2002","unstructured":"Mao R, Aylsworth AS, Potter N, Wilson WG, Breningstall G, Wick MJ et al (2002) Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. Am J Med Genet 110:338\u201345. doi: 10.1002\/ajmg.10467","journal-title":"Am J Med Genet"},{"key":"8348_CR33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajmg.a.20428","volume":"124A","author":"P Moretti","year":"2004","unstructured":"Moretti P, Blazo M, Garcia L, Amstrong D, Lewis RA, Roa B et al (2004) Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy. Am J Genet A 124A:392\u20136. doi: 10.1002\/ajmg.a.20428","journal-title":"Am J Genet A"},{"key":"8348_CR34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e31822e5627","volume":"77","author":"AR Parciorkowski","year":"2011","unstructured":"Parciorkowski AR, Shafrir Y, Hrivnak J, Patterson MC, Tennison MB, Clark HB et al (2011) Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms. Neurology 77:1055\u201360","journal-title":"Neurology"},{"key":"8348_CR35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12311-011-0315-9","volume":"11","author":"R Fabio Di","year":"2012","unstructured":"Di Fabio R, Santorelli F, Bertini E, Balestri M, Cursi L, Tessa A et al (2012) Infantile childhood onset of spinocerebellar ataxia type 2. Cerebellum 11:526\u201330. doi: 10.1007\/s12311-011-0315-9","journal-title":"Cerebellum"},{"key":"8348_CR36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/0883073808315622","volume":"23","author":"MB Ramocki","year":"2008","unstructured":"Ramocki MB, Chapieski L, McDonald RO, Fernandez F, Malphrus AD (2008) Spinocerebellar ataxia type 2 presenting with cognitive regression in childhood. J Child Neurol 23:999\u20131001. doi: 10.1177\/0883073808315622","journal-title":"J Child Neurol"},{"key":"8348_CR37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00415-008-0690-4","volume":"255","author":"A Abdel-Aleem","year":"2008","unstructured":"Abdel-Aleem A, Zaki MS (2008) Spinocerebellar ataxia type 2 in an Egyptian family presenting with polyphagia and marked CAG expansion in infancy. J Neurol 255:413\u20139. doi: 10.1007\/s00415-008-0690-4","journal-title":"J Neurol"},{"key":"8348_CR38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s004010050989","volume":"97","author":"R Estrada","year":"1999","unstructured":"Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol (Berl) 97:306\u201310. doi: 10.1007\/s004010050989","journal-title":"Acta Neuropathol (Berl)"},{"key":"8348_CR39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00401-005-1014-8","volume":"109","author":"K Gierga","year":"2005","unstructured":"Gierga K, B\u00fcrk K, Bauer M, Orozco Diaz G, Auburger G, Schultz C et al (2005) Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol 109:617\u201331. doi: 10.1007\/s00401-005-1014-8","journal-title":"Acta Neuropathol"},{"key":"8348_CR40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2990.2007.00933.x","volume":"34","author":"F Hoche","year":"2008","unstructured":"Hoche F, Seidel K, Brunt ER, Auburger G, Schols L, Burk K et al (2008) Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7). Neuropathol Appl Neurobiol 34:479\u201391. doi: 10.1111\/j.1365-2990.2007.00933.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8348_CR41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.73.4.450","volume":"73","author":"S Koyano","year":"2002","unstructured":"Koyano S, Iwabuchi K, Yagishita S, Kuroiwa Y, Uchihara T (2002) Paradoxical absence of nuclear inclusion in cerebellar purkinje cells of hereditary ataxias linked to CAG expansion. J Neuro Neurosurg Psychiatry 73:450\u20132. doi: 10.1136\/jnnp.73.4.450","journal-title":"J Neuro Neurosurg Psychiatry"},{"key":"8348_CR42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/brain\/awf060","volume":"125","author":"JT Pang","year":"2002","unstructured":"Pang JT, Giunti P, Chamberlain S, An SF, Vitaliani R, Scaravilli T et al (2002) Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. Brain 125:656\u201363. doi: 10.1093\/brain\/awf060","journal-title":"Brain"},{"key":"8348_CR43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2990.2004.00617.x","volume":"31","author":"U Rub","year":"2005","unstructured":"Rub U, Del Turco D, Burk K, D\u00edaz GO, Auburger G, Mittelbronn M et al (2005) Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2. Neuropathol Appl Neurobiol 31:127\u201340. doi: 10.1111\/j.1365-2990.2004.00617.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8348_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brainresrev.2006.08.003","volume":"53","author":"U Rub","year":"2007","unstructured":"Rub U, Seidel K, Ozerden I, Gierga K, Brunt ER, Schols L et al (2007) Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res Rev 53:235\u201349. doi: 10.1016\/j.brainresrev.2006.08.003","journal-title":"Brain Res Rev"},{"key":"8348_CR45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7","volume":"45","author":"DP Huynh","year":"1999","unstructured":"Huynh DP, Del Bigio MR, Ho DH, Pulst SM (1999) Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer\u2019s disease and spinocerebellar ataxia 2. Ann Neurol 45:232\u201341","journal-title":"Ann Neurol"},{"key":"8348_CR46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2990.2003.00504.x","volume":"29","author":"U Rub","year":"2003","unstructured":"Rub U, Schultz C, Del Tredici K, Gierga K, Reifenberger G, de Vos RA et al (2003) Anatomically based guidelines for systematic investigation of the central somatosensory system and their application to a spinocerebellar ataxia type 2 (SCA2) patient. Neuropathol Appl Neurobiol 29:418\u201333. doi: 10.1046\/j.1365-2990.2003.00504.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8348_CR47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1196\/annals.1325.040","volume":"1039","author":"SH Ying","year":"2005","unstructured":"Ying SH, Choi SI, Lee M, Perlman SL, Baloh RW, Toga AW et al (2005) Relative atrophy of the flocculus and ocular motor dysfunction in SCA2 and SCA6. Ann N Y Acad Sci 1039:430\u20135. doi: 10.1196\/annals.1325.040","journal-title":"Ann N Y Acad Sci"},{"key":"8348_CR48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"G Imbert","year":"1996","unstructured":"Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM et al (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nat Genet 14:285\u201391. doi: 10.1038\/ng1196-285","journal-title":"Nat Genet"},{"key":"8348_CR49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"MS Pulst","year":"1996","unstructured":"Pulst MS, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I et al (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14:269\u201376. doi: 10.1038\/ng1196-269","journal-title":"Nat Genet"},{"key":"8348_CR50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1196-277","volume":"14","author":"K Sanpei","year":"1996","unstructured":"Sanpei K, Takano H, Igarashi S, Sato T, Oyake M, Sasaki H et al (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 14:277\u201384. doi: 10.1038\/ng1196-277","journal-title":"Nat Genet"},{"key":"8348_CR51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.58.2.191","volume":"58","author":"EK Tan","year":"2001","unstructured":"Tan EK, Ashisawa T (2001) Genetic testing in spinocerebellar ataxias: defining a clinical role. Arch Neurol 58:191\u20135. doi: 10.1001\/pubs.ArchNeurol.-ISSN-0003-9942-58-2-nnr00011","journal-title":"Arch Neurol"},{"key":"8348_CR52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/geno.1997.5131","volume":"47","author":"S Sahba","year":"1998","unstructured":"Sahba S, Nechiporuk A, Figueroa KP, Nechiporuk T, Pulst SM (1998) Genomic structure of the human gene for spinocerebellar ataxia 2 (SCA2) on chromosome 12q24.1. Genomics 47:359\u201364. doi: 10.1006\/geno.1997.5131","journal-title":"Genomics"},{"key":"8348_CR53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajmg.10467","volume":"110","author":"R Mao","year":"2002","unstructured":"Mao R, Aylsworth AS, Potter N, Wilson WG, Breningstall G, Wick MJ et al (2002) Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. Am J Med Genet 110:338\u201345. doi: 10.1002\/ajmg.10467","journal-title":"Am J Med Genet"},{"key":"8348_CR54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/humu.10151","volume":"21","author":"AM Andr\u00e9s","year":"2002","unstructured":"Andr\u00e9s AM, Lao O, Soldevila M, Calafell F, Bertranpetit J (2002) Dynamics of CAG repeat loci revealed by the analysis of their variability. Hum Mutat 21:61\u201370. doi: 10.1002\/humu.10151","journal-title":"Hum Mutat"},{"key":"8348_CR55","first-page":"331","volume":"145","author":"JJ Maga\u00f1a","year":"2009","unstructured":"Maga\u00f1a JJ, Leyva-Garc\u00eda N, Cisneros B (2009) Pathogenesis of myotonic dystrophy type 1. Gac Med Mex 145:331\u20137","journal-title":"Gac Med Mex"},{"key":"8348_CR56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/WNL.55.4.569","volume":"55","author":"M Fern\u00e1ndez","year":"2000","unstructured":"Fern\u00e1ndez M, McClain ME, Mart\u00ednez RA, Snow K, Lipe H, Ravits J et al (2000) Late-onset SCA2:33 CAG repeats are sufficient to cause disease. Neurology 55:569\u201372","journal-title":"Neurology"},{"key":"8348_CR57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1525-1578(10)60689-7","volume":"4","author":"MO Dorschner","year":"2002","unstructured":"Dorschner MO, Barden D, Stephens K (2002) Diagnosis of five spinocerebellar ataxia disorders by multiplex amplification and capillary electrophoresis. J Mol Diagn 4:108\u201313. doi: 10.1016\/S1525-1578(10)60689-7","journal-title":"J Mol Diagn"},{"key":"8348_CR58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/brain\/121.3.459","volume":"121","author":"P Giunti","year":"1998","unstructured":"Giunti P, Sabbadini G, Sweeney MG, Davis MB, Veneziano L, Mantuano E et al (1998) The role of SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families: frequency, clinical and genetics correlates. Brain 121:459\u201367. doi: 10.1093\/brain\/121.3.459","journal-title":"Brain"},{"key":"8348_CR59","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/awh586","volume":"128","author":"SM Pulst","year":"2005","unstructured":"Pulst SM, Santos N, Wang D, Yang H, Huynh D, Vel\u00e1zquez L et al (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128:2297\u2013303. doi: 10.1093\/brain\/awh586","journal-title":"Brain"},{"key":"8348_CR60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archneur.64.7.1042","volume":"64","author":"DK Simon","year":"2007","unstructured":"Simon DK, Zheng K, Vel\u00e1zquez L, Figueroa KP, Falc\u00f3n N, Almaguer LE, Pulst SM (2007) Mitochondrial complex I gene variant associated with early age of onset in SCA2. Arch Neurol 64:1042\u20134. doi: 10.1001\/archneur.64.7.1042","journal-title":"Arch Neurol"},{"key":"8348_CR61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/hmg\/9.12.1753","volume":"9","author":"S Hayes","year":"2000","unstructured":"Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, Riess O et al (2000) CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9:1753\u20138. doi: 10.1093\/hmg\/9.12.1753","journal-title":"Hum Mol Genet"},{"key":"8348_CR62","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","volume":"76","author":"P Damme Van","year":"2011","unstructured":"Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V et al (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76:2066\u20132072","journal-title":"Neurology"},{"key":"8348_CR63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/hmg\/ddr045","volume":"20","author":"T Lee","year":"2011","unstructured":"Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O et al (2011) Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet 20:1697\u20131700. doi: 10.1093\/hmg\/ddr045","journal-title":"Hum Mol Genet"},{"key":"8348_CR64","doi-asserted-by":"crossref","first-page":"e17951","DOI":"10.1371\/journal.pone.0017951","volume":"6","author":"Z Yu","year":"2011","unstructured":"Yu Z, Zhu Y, Chen-Plotkin AS, Clay-Falcone D, McCluskey L, Elman L et al (2011) PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS One 6:e17951. doi: 10.1371\/journal.pone.0017951","journal-title":"PLoS One"},{"key":"8348_CR65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069\u20131075. doi: 10.1038\/nature09320","journal-title":"Nature"},{"key":"8348_CR66","doi-asserted-by":"crossref","first-page":"1925.e1","DOI":"10.1016\/j.neurobiolaging.2011.05.015","volume":"32","author":"Y Chen","year":"2011","unstructured":"Chen Y, Huang R, Tang Y, Chen K, Song W, Pan P et al (2011) Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 32:1925.e1\u20131925.e5. doi: 10.1016\/j.neurobiolaging.2011.05.015","journal-title":"Neurobiol Aging"},{"key":"8348_CR67","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneurol.2011.111","volume":"68","author":"H Daoud","year":"2011","unstructured":"Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, Lacomblez L et al (2011) Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. Arch Neurol 68:739\u2013742. doi: 10.1001\/archneurol.2011.111","journal-title":"Arch Neurol"},{"key":"8348_CR68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2011.08.021","volume":"45","author":"S Gispert","year":"2012","unstructured":"Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, Geisen C et al (2012) The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45:356\u2013361. doi: 10.1016\/j.nbd.2011.08.021","journal-title":"Neurobiol Dis"},{"key":"8348_CR69","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1212\/01.wnl.0000269323.21969.db","volume":"69","author":"P Charles","year":"2007","unstructured":"Charles P, Camuzat A, Benammar N, Sellal F, Dest\u00e9e A, Bonnet AM et al (2007) French Parkinson\u2019s Disease Genetic Study Group. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology 69:1970\u20131975","journal-title":"Neurology"},{"key":"8348_CR70","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/j.1432-1033.2004.04245.x","volume":"271","author":"M Albrecht","year":"2004","unstructured":"Albrecht M, Golatta M, Wullner U, Lengauer T (2004) Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem 271:3155\u201370. doi: 10.1111\/j.1432-1033.2004.04245.x","journal-title":"Eur J Biochem"},{"key":"8348_CR71","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2008.09.020","volume":"215","author":"S Loo van de","year":"2009","unstructured":"van de Loo S, Eich F, Nonis D, Auburger G, Nowock J (2009) Ataxin-2 associates with rough endoplasmic reticulum. Exp Neurol 215:110\u20138. doi: 10.1016\/j.expneurol.2008.09.020","journal-title":"Exp Neurol"},{"key":"8348_CR72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s109-1998-8098-0","volume":"76","author":"AF Neuwald","year":"1998","unstructured":"Neuwald AF, Koonin EV (1998) Ataxin-2, global regulators of bacterial gene expression, and spliceosomal snRNP proteins share a conserved domain. J Mol Med 76:3\u20135. doi: 10.1007\/s001090050184","journal-title":"J Mol Med"},{"key":"8348_CR73","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddl173","volume":"15","author":"TF Satterfield","year":"2006","unstructured":"Satterfield TF, Pallanck LJ (2006) Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet 15:2523\u201332. doi: 10.1093\/hmg\/ddl173","journal-title":"Hum Mol Genet"},{"key":"8348_CR74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12311-008-0019-y","volume":"7","author":"I Lastres-Becker","year":"2008","unstructured":"Lastres-Becker I, R\u00fcb U, Auburger G (2008) Spinocerebellar ataxia 2 (SCA2). Cerebellum 7:115\u2013124. doi: 10.1007\/s12311-008-0019-y","journal-title":"Cerebellum"},{"key":"8348_CR75","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.1074\/jbc.M105970200","volume":"277","author":"C Meunier","year":"2002","unstructured":"Meunier C, Bordereaux D, Porteu F, Gisselbrecht S, Chretien S, Courtois G (2002) Cloning and characterization of a family of proteins associated with Mp1. J Biol Chem 277:9139\u201347. doi: 10.1074\/jbc.M105970200","journal-title":"J Biol Chem"},{"key":"8348_CR76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1937-6448(08)01604-3","volume":"272","author":"S Tharun","year":"2009","unstructured":"Tharun S (2009) Roles of eukaryotic Lsm proteins in the regulation of mRNA function. Int Rev Cell Mol Biol 272:149\u201389. doi: 10.1016\/S1937-6448(08)01604-3","journal-title":"Int Rev Cell Mol Biol"},{"key":"8348_CR77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jmb.2004.11.024","volume":"346","author":"M Ralser","year":"2005","unstructured":"Ralser M, Albrecht M, Nonhoff U, Lengauer T, Lehrach H, Krobitsch S (2005) An integrative approach to gain insights into the cellular function of human ataxin-2. J Mol Biol 346:203\u201314. doi: 10.1016\/j.jmb.2004.11.024","journal-title":"J Mol Biol"},{"key":"8348_CR78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00438-004-1090-9","volume":"272","author":"J Bravo","year":"2005","unstructured":"Bravo J, Aguilar-Henonin L, Olmedo G, Guzm\u00e1n P (2005) Four distinct classes of proteins as interaction partners of the PABC domain of Arabidopsis thaliana Poly(A)-binding proteins. Mol Genet Genomics 272:651\u201365. doi: 10.1007\/s00438-004-1090-9","journal-title":"Mol Genet Genomics"},{"key":"8348_CR79","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/9.9.1303","volume":"9","author":"H Shibata","year":"2000","unstructured":"Shibata H, Huynh DP, Pulst SM (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum Mol Genet 9:1303\u201313. doi: 10.1093\/hmg\/9.9.1303","journal-title":"Hum Mol Genet"},{"key":"8348_CR80","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1101\/gad.1837009","volume":"23","author":"JA Lee","year":"2009","unstructured":"Lee JA, Tang ZZ, Black DL (2009) An inducible change in Fox-1\/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev 23:2284\u201393. doi: 10.1101\/gad.1837009","journal-title":"Genes Dev"},{"key":"8348_CR81","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","volume":"87","author":"JZ Tsien","year":"1996","unstructured":"Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327\u201338. doi: 10.1016\/S0092-8674(00)81827-9","journal-title":"Cell"},{"key":"8348_CR82","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2006.03.032","volume":"125","author":"J Lim","year":"2006","unstructured":"Lim J, Hao T, Shaw C, Patel AJ, Szabo G, Rual JF et al (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801\u201314","journal-title":"Cell"},{"key":"8348_CR83","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/nar\/gkh552","volume":"32","author":"P Villace","year":"2004","unstructured":"Villace P, Marion RM, Ortin J (2004) The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res 32:2411\u201320. doi: 10.1093\/nar\/jkh552","journal-title":"Nucleic Acids Res"},{"key":"8348_CR84","doi-asserted-by":"crossref","first-page":"13599","DOI":"10.1074\/jbc.M109.089540","volume":"285","author":"G Kozlov","year":"2010","unstructured":"Kozlov G, Safaee N, Rosenauer A, Gehring K (2010) Structural basis of binding of P-body-associated proteins GW182 and ataxin-2 by the MLLE domain of poly(A)-binding protein. J Biol Chem 285:13599\u2013606. doi: 10.1074\/jbc.M109.089540","journal-title":"J Biol Chem"},{"key":"8348_CR85","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1242\/dev.01352","volume":"131","author":"R Ciosk","year":"2004","unstructured":"Ciosk R, DePalma M, Priess JR (2004) ATX-2, the C. elegans ortholog of ataxin 2, functions in translational regulation in the germline. Development 131:4831\u201341. doi: 10.1242\/dev.01352","journal-title":"Development"},{"key":"8348_CR86","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/bst0300963","volume":"30","author":"N Kedersha","year":"2002","unstructured":"Kedersha N, Anderson P (2002) Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochem Soc Trans 30:963\u20139","journal-title":"Biochem Soc Trans"},{"key":"8348_CR87","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-9525(97)01269-9","volume":"13","author":"C Vernet","year":"1997","unstructured":"Vernet C, Artzt K (1997) STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13:479\u201384. doi: 10.1016\/S0168-9525(97)01269-9","journal-title":"Trends Genet"},{"key":"8348_CR88","doi-asserted-by":"crossref","first-page":"e10006","DOI":"10.1371\/journal.pone.0010006","volume":"5","author":"KD Swisher","year":"2010","unstructured":"Swisher KD, Parker R (2010) Localization to, and effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on stress granules in Saccharomyces cerevisiae. PLoS One 5:e10006. doi: 10.1371\/journal.pone.0010006","journal-title":"PLoS One"},{"key":"8348_CR89","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/hmg\/ddi321","volume":"14","author":"M Ralser","year":"2005","unstructured":"Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, Lehrach H et al (2005) Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet 14:2893\u2013909. doi: 10.1093\/hmg\/ddi321","journal-title":"Hum Mol Genet"},{"key":"8348_CR90","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/hmg\/ddg269","volume":"12","author":"DP Huynh","year":"2003","unstructured":"Huynh DP, Scoles DR, Nguyen D, Pulst SM (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet 12:2587\u201397. doi: 10.1093\/hmg\/ddg269","journal-title":"Hum Mol Genet"},{"key":"8348_CR91","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","volume":"105","author":"Y Imai","year":"2001","unstructured":"Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. Cell 105:891\u2013902. doi: 10.1016\/S0092-8674(01)00407-X","journal-title":"Cell"},{"key":"8348_CR92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/416183a","volume":"416","author":"P Soubeyran","year":"2002","unstructured":"Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I (2002) Cbl-CIN85-endophilin complex mediates ligand induced downregulation of EGF receptors. Nature 416:183\u20137. doi: 10.1038\/416183a","journal-title":"Nature"},{"key":"8348_CR93","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/genetics\/162.4.1687","volume":"162","author":"TF Satterfield","year":"2002","unstructured":"Satterfield TF, Jackson SM, Pallanck LJ (2002) A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics 162:1687\u2013702","journal-title":"Genetics"},{"key":"8348_CR94","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26:44\u201350. doi: 10.1038\/79162","journal-title":"Nat Genet"},{"issue":"2","key":"8348_CR95","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12311-009-0144-2","volume":"9","author":"A Matilla-Due\u00f1as","year":"2010","unstructured":"Matilla-Due\u00f1as A, S\u00e1nchez I, Corral-Juan M, D\u00e1valos A, Alvarez R, Latorre P (2010) Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias. Cerebellum 9(2):148\u201366. doi: 10.1007\/s12311-009-0144-2","journal-title":"Cerebellum"},{"key":"8348_CR96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA et al (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548. doi: 10.1016\/S0092-8674(00)80513-9","journal-title":"Cell"},{"key":"8348_CR97","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP et al (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"8348_CR98","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/hmg\/ddg175","volume":"12","author":"DP Huynh","year":"2003","unstructured":"Huynh DP, Yang HT, Vakharia H, Nguyen D, Pulst SM (2003) Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupt the Golgi complex and causes cell death. Hum Mol Genet 12:1485\u20131496. doi: 10.1093\/hmg\/ddg175","journal-title":"Hum Mol Genet"},{"key":"8348_CR99","first-page":"805","volume":"57","author":"S Koyano","year":"1999","unstructured":"Koyano S, Uchihara T, Fujigasaki H, Nakamura A, Yagishita S, Iwabuchi K (1999) Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci Lett 57:805\u2013810. doi: 10.1016\/S0304-3940(99)00656-4","journal-title":"Neurosci Lett"},{"key":"8348_CR100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004010100364","volume":"102","author":"T Uchihara","year":"2001","unstructured":"Uchihara T, Fujigasaki H, Koyano S, Nakamura A, Yagishita S, Iwabuchi K (2001) Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias-triple-labeling immunofluorescence study. Acta Neuropathol 102:149\u2013152. doi: 10.1007\/s004010100364","journal-title":"Acta Neuropathol"},{"key":"8348_CR101","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366. doi: 10.1016\/S0092-8674(00)81782-1","journal-title":"Cell"},{"key":"8348_CR102","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/hmg\/7.9.1355","volume":"7","author":"A Lunkes","year":"1998","unstructured":"Lunkes A, Mandel JL (1998) A cellular model that recapitulates major pathogenic steps of Hungtington\u2019s disease. Hum Mol Genet 7:1355\u20131361. doi: 10.1093\/hmg\/7.9.1355","journal-title":"Hum Mol Genet"},{"key":"8348_CR103","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1098\/rstb.1999.0453","volume":"354","author":"A Lunkes","year":"1999","unstructured":"Lunkes A, Trottier Y, Fagart J, Schultz P, Zeder-Lutz G, Moras D et al (1999) Properties of polyglutamine expansion in vitro and in a cellular model for Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354:1013\u20131019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8348_CR104","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al (1996) Exon 1 of HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506. doi: 10.1016\/S0092-8674(00)81369-0","journal-title":"Cell"},{"key":"8348_CR105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1098\/rstb.1999.0451","volume":"354","author":"N Aronin","year":"1999","unstructured":"Aronin N, Kim M, Laforet G, DiFiglia M (1999) Are there multiple pathways in the pathogenesis of Huntington\u2019s disease? Philos Trans R Soc Lond B Biol Sci 354:995\u20131003","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8348_CR106","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1098\/rstb.1999.0456","volume":"354","author":"PH Reddy","year":"1999","unstructured":"Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA (1999) Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354:1035\u20131045","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8348_CR107","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/00207450600936668","volume":"117","author":"V Tarlac","year":"2007","unstructured":"Tarlac V, Turnbull V, Stefani D, Kelly L, Walsh R, Storey E (2007) Inclusion formation by ataxins-1,-2,-3, and-7. Int J Neurosci 117:1289\u20131314. doi: 10.1080\/00207450600936668","journal-title":"Int J Neurosci"},{"key":"8348_CR108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2005.09.020","volume":"392","author":"J Aguiar","year":"2006","unstructured":"Aguiar J, Fern\u00e1ndez J, Aguilar A, Mendoza Y, V\u00e1zquez M, Su\u00e1rez J et al (2006) Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter causes specific Purkinje cell degeneration in transgenic mice. Neurosci Lett 392:202\u20136. doi: 10.1016\/j.neulet.2005.09.020","journal-title":"Neurosci Lett"},{"key":"8348_CR109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2004.08.044","volume":"1027","author":"VJ Turnbull","year":"2004","unstructured":"Turnbull VJ, Storey E, Tarlac V, Walsh R, Stefani D, Clark R et al (2004) Different ataxin-2 antibodies display different immunoreactive profiles. Brain Res 1027:103\u2013116. doi: 10.1016\/j.brainres.2004.08.044","journal-title":"Brain Res"},{"key":"8348_CR110","first-page":"939","volume":"93","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS et al (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 93:939\u2013949. doi: 10.1016\/S0896-6273(00)80943-5","journal-title":"Neuron"},{"key":"8348_CR111","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ng0696-196","volume":"13","author":"H Ikeda","year":"1996","unstructured":"Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A (1996) Expanded polyglutamine in the Machado-Joseph disease protein induce cell death in vitro and in vivo. Nat Genet 13:196\u2013202. doi: 10.1038\/ng0696-196","journal-title":"Nat Genet"},{"key":"8348_CR112","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/hmg\/7.4.693","volume":"7","author":"DE Merry","year":"1998","unstructured":"Merry DE, Kobayashi Y, Bailey CK, Taye AA, Fischbeck KH (1998) Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet 7:693\u2013701. doi: 10.1093\/hmg\/7.4.693","journal-title":"Hum Mol Genet"},{"key":"8348_CR113","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R et al (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158\u20139167. doi: 10.1074\/jbc.273.15.9158","journal-title":"J Biol Chem"},{"key":"8348_CR114","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, haigh B, Bissada N, Lu G et al (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191. doi: 10.1016\/j.cell.2006.04.026","journal-title":"Cell"},{"key":"8348_CR115","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","volume":"24","author":"D Goti","year":"2004","unstructured":"Goti D, Katzen SM, Mez J, Kurtis N, Kiluk J, Ben-Ha\u00efem L et al (2004) A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci 24:10266\u201379. doi: 10.1523\/JNEUROSCI.2734-04.2004","journal-title":"J Neurosci"},{"key":"8348_CR116","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2007.06.005","volume":"27","author":"VF Colomer Gould","year":"2007","unstructured":"Colomer Gould VF, Goti D, Pearce D, Gonzalez GA, Gao H, Bermudez de Leon M et al (2007) A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease like transgenic mice. Neurobiol Dis 27:362\u2013369. doi: 10.1016\/j.nbd.2007.06.005","journal-title":"Neurobiol Dis"},{"key":"8348_CR117","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1471-4159.2004.02369.x","volume":"89","author":"SJ Berke","year":"2004","unstructured":"Berke SJ, Schmied FA, Brunt ER, Ellerby LM, Paulson HL (2004) Caspase-mediated proteolysis of polyglutamine disease protein ataxin-3. J Neurochem 89:908\u2013918. doi: 10.1111\/j.1471-4159.2004.02369.x","journal-title":"J Neurochem"},{"key":"8348_CR118","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mcn.2008.09.007","volume":"40","author":"SC Warby","year":"2009","unstructured":"Warby SC, Doty CN, Graham RK, Shively J, Singaraja RR, Hayden MR (2009) Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol Cell Neurosci 40:121\u2013127. doi: 10.1016\/j.mcn.2008.09.007","journal-title":"Mol Cell Neurosci"},{"key":"8348_CR119","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S et al (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2:831\u2013837. doi: 10.1016\/S1534-5807(02)00188-0","journal-title":"Dev Cell"},{"key":"8348_CR120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0953-816X.2003.03131.x","volume":"19","author":"H Rangone","year":"2004","unstructured":"Rangone H, Poizat G, Troncoso J, Ross CA, McDonald ME, Saudou F et al (2004) The serum-and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci 19:273\u2013279. doi: 10.1111\/j.0953-816X.2003.03131.x","journal-title":"Eur J Neurosci"},{"key":"8348_CR121","doi-asserted-by":"crossref","first-page":"23686","DOI":"10.1074\/jbc.M513507200","volume":"281","author":"B Schilling","year":"2006","unstructured":"Schilling B, Gafni J, Torcassi C, Cong X, Row RH, LaFevre-Bernt MA et al (2006) Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. J Biol Chem 281:23686\u201323697. doi: 10.1074\/jbc.M513507200","journal-title":"J Biol Chem"},{"key":"8348_CR122","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","volume":"279","author":"J Gafni","year":"2004","unstructured":"Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus. J Biol Chem 279:20211\u201320220. doi: 10.1074\/jbc.M401267200","journal-title":"J Biol Chem"},{"key":"8348_CR123","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2007.03.160","volume":"357","author":"E Fei","year":"2007","unstructured":"Fei E, Jia N, Zhang T, Ma X, Wang H, Liu C et al (2007) Phosphorylation of ataxin-3 by glycogen synthase kinase 3beta at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun 357:487\u2013492. doi: 10.1016\/j.bbrc.2007.03.160","journal-title":"Biochem Biophys Res Commun"},{"key":"8348_CR124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/hmg\/ddp274","volume":"18","author":"T Mueller","year":"2009","unstructured":"Mueller T, Breuer P, Schmitt I, Walter J, Evert BO, W\u00fcllner U (2009) CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum Mol Genet 18:121\u2013136. doi: 10.1093\/hmg\/ddp274","journal-title":"Hum Mol Genet"},{"key":"8348_CR125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11\u201322. doi: 10.1038\/nrn1587","journal-title":"Nat Rev Neurosci"},{"key":"8348_CR126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman MY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15\u201332. doi: 10.1016\/S0896-6273(01)00177-5","journal-title":"Neuron"},{"key":"8348_CR127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mds.10192","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W, Back C, Gerschlager W, Laccone F, Alesch F (2003) Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2. Mov Disord 18:222\u20135. doi: 10.1002\/mds.10192","journal-title":"Mov Disord"},{"key":"8348_CR128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mds.21338","volume":"22","author":"HJ Freund","year":"2007","unstructured":"Freund HJ, Barnikol UB, Nolte D, Treuer H, Auburger G, Tass PA et al (2007) Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-A unusual clinical benefit. Mov Disord 22:732\u20135. doi: 10.1002\/mds.21338","journal-title":"Mov Disord"},{"key":"8348_CR129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","volume":"74","author":"G Ristori","year":"2010","unstructured":"Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M et al (2010) Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial (CME) (LOE Classification). Neurology 74:839\u201345","journal-title":"Neurology"},{"issue":"10","key":"8348_CR130","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s11064-011-0496-0","volume":"36","author":"L Vel\u00e1zquez-P\u00e9rez","year":"2011","unstructured":"Vel\u00e1zquez-P\u00e9rez L, Rodr\u00edguez-Chanfrau J, Garc\u00eda-Rodr\u00edguez JC, S\u00e1nchez-Cruz G, Aguilera-Rodr\u00edguez R, Rodr\u00edguez-Labrada R et al (2011) Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial. Neurochem Res 36(10):1793\u2013800. doi: 10.1007\/s11064-011-0496-0","journal-title":"Neurochem Res"},{"key":"8348_CR131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10:816\u201320","journal-title":"Nat Med"},{"key":"8348_CR132","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q et al (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA 102:5820\u20135825. doi: 10.1073\/pnas.0501507102","journal-title":"Proc Natl Acad Sci USA"},{"key":"8348_CR133","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron E, Denovan-Wrigth EM, Nash K, Lewin AS, Mandel RJ (2005) Intrastratial rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice. Mol Ther 12:618\u2013633. doi: 10.1016\/j.ymthe.2005.05.006","journal-title":"Mol Ther"},{"key":"8348_CR134","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","volume":"16","author":"NR Franich","year":"2008","unstructured":"Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D (2008) AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington\u2019s disease. Mol Ther 16:947\u2013956. doi: 10.1038\/mt.2008.50","journal-title":"Mol Ther"},{"key":"8348_CR135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","volume":"343","author":"Y Machida","year":"2006","unstructured":"Machida Y, Okada T, Kurosawa M, Oyama F, Ozawa K, Nukina N (2006) rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem Biophys Res Commun 343:190\u2013197. doi: 10.1016\/j.bbrc.2006.02.141","journal-title":"Biochem Biophys Res Commun"},{"key":"8348_CR136","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"YL Wang","year":"2005","unstructured":"Wang YL, Liu W, Wada E, Murata M, Wada K, Kanazawa I (2005) Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA. Neurosci Res 53:241\u2013249. doi: 10.1016\/j.neures.2005.06.021","journal-title":"Neurosci Res"},{"key":"8348_CR137","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/hmg\/11.2.175","volume":"11","author":"NJ Caplen","year":"2002","unstructured":"Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA (2002) Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum Mol Genet 11:175\u2013184. doi: 10.1093\/hmg\/11.2.175","journal-title":"Hum Mol Genet"},{"key":"8348_CR138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-211-73574-9_7","volume":"72","author":"E Koutsilieri","year":"2007","unstructured":"Koutsilieri E, Rethwilm A, Scheller C (2007) The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders. J Neural Transm Suppl 72:43\u201349","journal-title":"J Neural Transm Suppl"},{"key":"8348_CR139","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2005.11.008","volume":"48","author":"NM Bonini","year":"2005","unstructured":"Bonini NM, La Spada AR (2005) Silencing polyglutamine degeneration with RNAi. Neuron 48:715\u20138. doi: 10.1016\/jneuron.2005.11.008","journal-title":"Neuron"},{"key":"8348_CR140","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL et al (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100:7195\u20137200. doi: 10.1073\/pnas.1231012100","journal-title":"Proc Natl Acad Sci USA"},{"key":"8348_CR141","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ana.20141","volume":"56","author":"Y Li","year":"2004","unstructured":"Li Y, Yokota T, Matsumura R, Taira K, Misuzawa H (2004) Sequence dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA. Ann Neurol 56:124\u2013129. doi: 10.1002\/ana.20141","journal-title":"Ann Neurol"},{"key":"8348_CR142","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","volume":"3","author":"S Alves","year":"2008","unstructured":"Alves S, Nascimento-Ferreira I, Auregan G, Hassig R, Dufour N, Brouillet E et al (2008) Allele-specific RNA silencing of mutant ataxin 3 mediates protection in a rat model of Machado-Joseph disease. PLoS One 3:e3341. doi: 10.1371\/journal.pone.0003341","journal-title":"PLoS One"},{"key":"8348_CR143","doi-asserted-by":"crossref","first-page":"e7232","DOI":"10.1371\/journal.pone.0007232","volume":"4","author":"J Scholefield","year":"2009","unstructured":"Scholefield J, Greenberg LJ, Weinberg MS, Arbuthnot PB, Abdelgany A, Wood MJ (2009) Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correlation of a SCA7 phenotype. PLoS One 4:e7232. doi: 10.1371\/journal.pone.0007232","journal-title":"PLoS One"},{"key":"8348_CR144","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Engelman J, Friedlander RM (2009) Allele-specific silencing of mutant Huntington\u2019s disease gene. J Neurochem 108:82\u201390. doi: 10.1111\/j.1471-4159.2008.05734.x","journal-title":"J Neurochem"},{"key":"8348_CR145","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","volume":"49","author":"KT Gagnon","year":"2010","unstructured":"Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF et al (2010) Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry 49:10166\u201310178. doi: 10.1021\/bi101208k","journal-title":"Biochemistry"},{"key":"8348_CR146","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","volume":"27","author":"J Hu","year":"2009","unstructured":"Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR (2009) Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat Biotechnol 27:478\u2013484. doi: 10.1038\/nbt.1539","journal-title":"Nat Biotechnol"},{"key":"8348_CR147","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/oli.2005.15.298","volume":"15","author":"T Kubodera","year":"2005","unstructured":"Kubodera T, Yokota T, Ishikawa K, Mizusawa H (2005) New RNAi strategy for selective suppression of a mutant allele in polyglutamine disease. Oligonucleotides 15:298\u2013302. doi: 10.1089\/oli.2005.15.298","journal-title":"Oligonucleotides"},{"key":"8348_CR148","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","volume":"4","author":"BL Davidson","year":"2003","unstructured":"Davidson BL, Breakefield XO (2003) Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci 4:353\u2013364. doi: 10.1038\/nrn1104","journal-title":"Nat Rev Neurosci"},{"key":"8348_CR149","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14712591003604690","volume":"10","author":"Y Tang","year":"2010","unstructured":"Tang Y, Cummins J, Huard J, Wang B (2010) AAV-directed muscular dystrophy gene therapy. Expert Opin Biol Ther 10:395\u2013408. doi: 10.1517\/14712591003604690","journal-title":"Expert Opin Biol Ther"},{"key":"8348_CR150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","volume":"3","author":"S Sarkar","year":"2007","unstructured":"Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL et al (2007) Small molecules enhance autophagy and reduce toxicity in Huntington\u2019s disease models. Nat Chem Biol 3:331\u2013338. doi: 10.1038\/nchembio883","journal-title":"Nat Chem Biol"},{"key":"8348_CR151","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqui FH et al (2008) Novel targets for Huntington\u2019s disease in an mTOR independent autophagy pathway. Nat Chem Biol 4:295\u2013305. doi: 10.1038\/nchembio.79","journal-title":"Nat Chem Biol"},{"key":"8348_CR152","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1093\/hmg\/ddn218","volume":"17","author":"HK Wong","year":"2008","unstructured":"Wong HK, Bauer PO, Kurosawa M et al (2008) Blocking acid-sensing ion channel 1 alleviates Huntington\u2019s disease pathology via an ubiquitin-proteasome system-dependent mechanism. Hum Mol Genet 17:3223\u201335. doi: 10.1093\/hmg\/ddn218","journal-title":"Hum Mol Genet"},{"key":"8348_CR153","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","volume":"40","author":"SK Pollitt","year":"2003","unstructured":"Pollitt SK, Pallos J, Shao J, Desai UA, Ma AA, Thompson LM, Marsh JL, Diamond MI (2003) A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40:685\u201394. doi: 10.1016\/S0896-6273(03)00697-4","journal-title":"Neuron"},{"key":"8348_CR154","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00795-008-0401-3","volume":"41","author":"S Tanaka","year":"2008","unstructured":"Tanaka S, Dan C, Kawano H, Omoto M, Ishihara T (2008) Pathological study amyloidosis in Cygnus olor (mute swan) and other waterfowl. Med Mol Morphol 41:99\u2013108. doi: 10.1007\/s00795-008-0401-3","journal-title":"Med Mol Morphol"},{"key":"8348_CR155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I S\u00e1nchez","year":"2003","unstructured":"S\u00e1nchez I, Mahlke C, Yuan J (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421:373\u2013379. doi: 10.1038\/nature01301","journal-title":"Nature"},{"key":"8348_CR156","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2006.09.015","volume":"25","author":"NI Wood","year":"2007","unstructured":"Wood NI, Pallier PN, Wanderer J, Morton AJ (2007) Systemic administration of Congo red does not improve motor or cognitive function in R6\/2 mice. Neurobiol Dis 25:342\u201353. doi: 10.1016\/j.nbd.2006.09.015","journal-title":"Neurobiol Dis"},{"key":"8348_CR157","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/hmg\/ddg144","volume":"12","author":"Y Nagai","year":"2003","unstructured":"Nagai Y, Fujikake N, Ohno K, Higashiyama H, Popiel HA, Rahadian J et al (2003) Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. Hum Mol Genet 12:1253\u20131259. doi: 10.1093\/hmg\/ddg144","journal-title":"Hum Mol Genet"},{"key":"8348_CR158","doi-asserted-by":"crossref","unstructured":"Popiel HA, Nagai Y, Fujikake N, Toda T. Protein transduction domain-mediated delivery of QBP1 supresses polyglutamine-induced neurodegeneration in vivo. Mol Ther 15:303-309. doi: 10.1038\/sj.mt.6300045","DOI":"10.1038\/sj.mt.6300045"},{"key":"8348_CR159","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","volume":"8","author":"MV Karpuj","year":"2002","unstructured":"Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R et al (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8:143\u20139. doi: 10.1038\/nm0202-143","journal-title":"Nat Med"},{"key":"8348_CR160","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Kubilus JK, Jeitner TM et al (2002) Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease. J Neurosci 22:8942\u201350","journal-title":"J Neurosci"},{"key":"8348_CR161","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0298-111","volume":"18","author":"S Igarashi","year":"1998","unstructured":"Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H et al (1998) Suppression of aggregate formation and apoptosis by tansglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18:111\u20137. doi: 10.1038\/ng0298-111","journal-title":"Nat Genet"},{"key":"8348_CR162","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1074\/jbc.M709674200","volume":"283","author":"MJ Friedman","year":"2008","unstructured":"Friedman MJ, Wang CE, Li XJ, Li S (2008) Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. J Biol Chem 283:8283\u20138290. doi: 10.1074\/jbc.M709674200","journal-title":"J Biol Chem"},{"key":"8348_CR163","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(03)00657-8","volume":"348","author":"SJ Kim","year":"2003","unstructured":"Kim SJ, Kim TS, Hong S, Rhim H, Kim IY, Kang S (2003) Oxidative stimuli affect polyglutamine aggregation and cell death in human mutant ataxin-1 expressing cells. Neurosci Lett 348:21\u201324. doi: 10.1016\/S0304-3940(03)00657-8","journal-title":"Neurosci Lett"},{"key":"8348_CR164","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM et al (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22:1592\u20139","journal-title":"J Neurosci"},{"key":"8348_CR165","doi-asserted-by":"crossref","first-page":"907","DOI":"10.33588\/rn.3910.2004331","volume":"39","author":"I P\u00e9rez-\u00c1vila","year":"2004","unstructured":"P\u00e9rez-\u00c1vila I, Fern\u00e1ndez-Vieitez JA, Mart\u00ednez-G\u00f3ngora E, Ochoa-Mastrapa R, Vel\u00e1zquez-Manresa MG (2004) Effects of a physical training program on quantitative neurological indices in mild stage type 2 spinocerebellar ataxia patients. Rev Neurol 39:907\u201310","journal-title":"Rev Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-012-8348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-012-8348-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-012-8348-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:49:50Z","timestamp":1744166990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-012-8348-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,21]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["8348"],"URL":"https:\/\/doi.org\/10.1007\/s12035-012-8348-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,21]]}}}